Skip to main content

Table 3 Characteristics of patients with large vessel occlusion and a positive history of ischemic stroke, subdivided into patients with and without the intake of platelet aggregation inhibitors (PAI) or oral anticoagulants (OAC) at admission. For intergroup differences, chi-square test was used for binary variables and Mann-Whitney test for ordinal or numeric scaled variables, a p-value < 0.05 was considered significant and marked in bold. Abbreviations: NIHSS – National Institute of Health Stroke Scale, mRS – modified Rankin Scale

From: Large-vessel-occlusion in patients with previous ischemic stroke: an analysis of adherence to secondary preventive medication for different etiologies

Recurrent stroke

PAI or OAC

 

Yes (n = 116)

No (n = 44)

p-value

Age

74.5 ± 10.8

72.9 ± 13.8

0.69

Posterior circulation %positive

8; 6.9%

5; 11.4%

0.4

Anterior circulation %positive

108; 93.1%

39; 88.6%

0.4

Sex %female

56; 48.3%

21; 47.7%

0.65

Died %

29; 25.0%

5; 11.4%

0.08

Etiology

   

Cryptogenic

13; 11.2%

6; 13.6%

0.97

Large-artery sclerosis

43; 37.1%

17; 38.6%

Cardioembolism

57; 49.1%

20; 45.5%

Others

3; 2.6%

1; 2.3%

Mechanical thrombectomy %yes

50; 43.1%

18; 40.9%

0.6

Systemic thrombolysis %yes

43; 37.1%

14; 31.8%

0.47

Statins %yes

68; 58.6%

13; 29.5%

< 0.01

Cholesterol ≥ 200 mg/dl at admission %yes

12; 10.3%

6; 13.6%

0.56

Diabetes mellitus %yes

37; 31.9%

18; 40.9%

0.3

Arterial hypertension %yes

102; 87.9%

35; 79.5%

0.23

Atrial fibrillation %yes

58; 50%

25; 56.8%

0.41

NIHSS at admission (median)

12 (7–18)

10 (5–14)

0.12

NIHSS at discharge (median)

3 (1–10)

6 (2–13)

0.23

mRS at admission

1 (1–3)

1 (0–2)

0.48

mRS at discharge

4 (2–6)

4 (2–5)

0.36